| Literature DB >> 33484095 |
Viviana Mendoza Ramos1,2, Charlotte Paulyn3, Leen Van den Steen1, Maria E Hernandez-Diaz Huici2, Marc De Bodt1,2,3, Gwen Van Nuffelen1,2,3.
Abstract
BACKGROUND: The articulatory accuracy of patients with dysarthria is one of the most affected speech dimensions with a high impact on speech intelligibility. Behavioural treatments of articulation can either involve direct or indirect approaches. The latter have been thoroughly investigated and are generally appreciated for their almost immediate effects on articulation and intelligibility. The number of studies on (short-term) direct articulation therapy is limited. AIMS: To investigate the effects of short-term, boost articulation therapy (BArT) on speech intelligibility in patients with chronic or progressive dysarthria and the effect of severity of dysarthria on the outcome. METHODS & PROCEDURES: The study consists of a two-group pre-/post-test design to assess speech intelligibility at phoneme and sentence level and during spontaneous speech, automatic speech and reading a phonetically balanced text. A total of 17 subjects with mild to severe dysarthria participated in the study and were randomly assigned to either a patient-tailored, intensive articulatory drill programme or an intensive minimal pair training. Both training programmes were based on the principles of motor learning. Each training programme consisted of five sessions of 45 min completed within one week. OUTCOMES &Entities:
Keywords: dysarthria; intelligibility; segmental articulation therapy
Year: 2021 PMID: 33484095 PMCID: PMC8048921 DOI: 10.1111/1460-6984.12595
Source DB: PubMed Journal: Int J Lang Commun Disord ISSN: 1368-2822 Impact factor: 3.020
Characteristics of the participants
| Participant | Intervention | Sex | Age (years) | Neurological pathology | Type of dysarthria | Severity dysarthria | MoCa score | SHI score |
|---|---|---|---|---|---|---|---|---|
| 1 | AD | Male | 56 | Idiopathic | Flaccid | Mild | 24 | 27 |
| 2 | AD | Male | 55 | Cerebellar ataxia | Spastic | Mild | 24 | 32 |
| 3 | AD | Male | 38 | Steinert disease | Hypokinetic | Moderate | 25 | 24 |
| 4 | AD | Male | 60 | Idiopathic | Mixed | Severe | 29 | 42 |
| 5 | AD | Female | 36 | Friedreich ataxia | Atactic | Mild | 28 | 18 |
| 6 | AD | Female | 84 | ALS | Mixed | Severe | 18 | 42 |
| 7 | AD | Female | 72 | Parkinson's Disease | Hypokinetic | Severe | 22 | 50 |
| 8 | AD | Female | 75 | Parkinson's Disease | Hypokinetic | Mild | 21 | 41 |
| 9 | MP | Male | 81 | Idiopathic | Flaccid | Severe | 22 | 37 |
| 10 | MP | Male | 98 | Parkinson's Disease | Hypokinetic | Moderate | 25 | 22 |
| 11 | MP | Female | 85 | ALS | Mixed | Severe | 26 | 39 |
| 12 | MP | Male | 35 | Friedreich ataxia | Atactic | Moderate | 27 | 12 |
| 13 | MP | Male | 63 | Parkinson's Disease | Hypokinetic | Mild | 27 | 19 |
| 14 | MP | Male | 81 | Steinert Disease | Hypokinetic | Moderate | 21 | 26 |
| 15 | MP | Male | 70 | Idiopathic | Flaccid | Moderate | 25 | 9 |
| 16 | MP | Female | 92 | TIA | Mixed | Severe | 20 | 25 |
| 17 | MP | Male | 53 | Parkinson's Disease | Hypokinetic | Mild | 25 | 23 |
Notes: a: Intervention: AD, articulatory drill; and MP, minimal pairs.
Score of the cognitive test Montreal Cognitive Assessment (score range: 0−30, score ≥ 26 = normal cognitive functioning).
Score of the Speech Handicap Index (score range: 0–60; score < 14 no impact, 14–22 light, 23–31 moderate, > 31 severe impact).
ALS, amyotrophic laterals sclerosis; TIA, transient ischemic attack.
Figure 1Intervention design. Components with ‘(1)’ are exclusively intended for the intervention articulatory drill; components with ‘(2)’ are intended for the intervention of minimal pairs; and when nothing is included, the parts are common for both interventions. *The SLP scores each word by means of a scoring form; and **feedback .
Summary of effect sizes of each speech tasks and time point for intelligibility (n = 17)
| Baseline | Post‐measurement | |
|---|---|---|
|
| ||
| Mean ± SD | 72 ± 14 | 78 ± 16 |
|
|
| |
| Cohen's | 0.41 | |
|
| ||
| Mean ± SD | 69 ± 25 | 75 ± 21 |
|
|
| |
| Cohen's | 0.27 | |
|
| ||
| Mean ± SD | 56 ± 32 | 60± 30 |
|
| 0.075 | |
| Cohen's | 0.13 | |
|
| ||
| Mean ± SD | 67 ± 26 | 70 ± 27 |
|
| 0.292 | |
| Cohen's | 0.12 | |
|
| ||
| Mean ± SD | 77 ± 22 | 81 ± 22 |
|
|
| |
| Cohen's | 0.19 |
Note: Significant p‐values and large effect sizes (> 0.8) reflecting training effects are denoted in bold.
Summary of effect sizes by groups of DSLs and time point
| Mild ( | Moderate ( | Severe ( | ||||
|---|---|---|---|---|---|---|
| Baseline | Post‐measurement | Baseline | Post‐measurement | Baseline | Post‐measurement | |
|
| ||||||
| Mean ± SD | 82 ± 8 | 90 ± 5 | 78 ± 9 | 83 ± 8 | 58 ± 11 | 63 ± 15 |
|
|
| 0.211 | 0.197 | |||
| Corrected | 0.114 | 0.394 | 0.394 | |||
| Cohen's |
| 0.70 | 0.41 | |||
|
| ||||||
| Mean ± SD | 88 ± 10 | 95± 3 | 79 ± 13 | 79 ± 9 | 42 ± 19 | 53 ± 15 |
|
| 0.051 | 0.861 |
| |||
| Corrected | 0.102 | 0.861 |
| |||
| Cohen's |
| 0.00 | 0.70 | |||
|
| ||||||
| Mean ± SD | 94 ± 6 | 98 ± 2 | 87 ± 8 | 86 ± 10 | 53 ± 19 | 59 ± 23 |
|
| 0.076 | 0.640 |
| |||
| Corrected | 0.152 | 0.64 |
| |||
| Cohen's |
| –0.12 | 0.32 | |||
Corrected p‐values after the Bonferroni–Holm correction for multiple testing are added after the raw p‐values.
Significant p‐values and large effect sizes (> 0.8) reflecting training effects are denoted in bold.
Figure 2Training effects of the BArT divided by DSLs. [Color figure can be viewed at wileyonlinelibrary.com]
Figure 3FCR and Intelligibility (NSVO) before and after therapy. [Color figure can be viewed at wileyonlinelibrary.com]